{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:31:42Z","timestamp":1790289102055,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T00:00:00Z","timestamp":1242086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T00:00:00Z","timestamp":1242086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/tpj.2009.19","type":"journal-article","created":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T09:58:42Z","timestamp":1242122322000},"page":"347-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients"],"prefix":"10.1038","volume":"9","author":[{"given":"D","family":"Caronia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pati\u00f1o-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R L","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zalacain-D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Pita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L T","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Sierrasesumaga-Ariznabarreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gonz\u00e1lez-Neira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,12]]},"reference":[{"key":"BFtpj200919_CR1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1634\/theoncologist.9-4-422","volume":"9","author":"N Marina","year":"2004","unstructured":"Marina N, Gebhardt M, Teot L, Gorlick R . Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 2004; 9: 422\u2013441.","journal-title":"Oncologist"},{"key":"BFtpj200919_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ctrv.2006.05.005","volume":"32","author":"A Longhi","year":"2006","unstructured":"Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G . Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 2006; 32: 423\u2013436.","journal-title":"Cancer Treat Rev"},{"key":"BFtpj200919_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G","volume":"69","author":"DB Glasser","year":"1992","unstructured":"Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G . Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience. Cancer 1992; 69: 698\u2013708.","journal-title":"Cancer"},{"key":"BFtpj200919_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","volume":"20","author":"SS Bielack","year":"2002","unstructured":"Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002; 20: 776\u2013790.","journal-title":"J Clin Oncol"},{"key":"BFtpj200919_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1586\/14737140.6.7.1075","volume":"6","author":"AJ Chou","year":"2006","unstructured":"Chou AJ, Gorlick R . Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert Rev Anticancer Ther 2006; 6: 1075\u20131085.","journal-title":"Expert Rev Anticancer Ther"},{"key":"BFtpj200919_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","volume":"33","author":"CA Rabik","year":"2007","unstructured":"Rabik CA, Dolan ME . Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 2007; 33: 9\u201323.","journal-title":"Cancer Treat Rev"},{"key":"BFtpj200919_CR7","doi-asserted-by":"publisher","first-page":"10004","DOI":"10.1021\/bi960453+","volume":"35","author":"DB Zamble","year":"1996","unstructured":"Zamble DB, Mu D, Reardon JT, Sancar A, Lippard SJ . Repair of cisplatin\u2014DNA adducts by the mammalian excision nuclease. Biochemistry 1996; 35: 10004\u201310013.","journal-title":"Biochemistry"},{"key":"BFtpj200919_CR8","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S0006-2952(00)00448-2","volume":"60","author":"M Dabholkar","year":"2000","unstructured":"Dabholkar M, Thornton K, Vionnet J, Bostick-Bruton F, Yu JJ, Reed E . Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues. Biochem Pharmacol 2000; 60: 1611\u20131619.","journal-title":"Biochem Pharmacol"},{"key":"BFtpj200919_CR9","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1200\/JCO.2006.05.8768","volume":"24","author":"M Quintela-Fandino","year":"2006","unstructured":"Quintela-Fandino M, Hitt R, Medina PP, Gamarra S, Manso L, Cortes-Funes H et al. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy. J Clin Oncol 2006; 24: 4333\u20134339.","journal-title":"J Clin Oncol"},{"key":"BFtpj200919_CR10","first-page":"8654","volume":"61","author":"DJ Park","year":"2001","unstructured":"Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ et al. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res 2001; 61: 8654\u20138658.","journal-title":"Cancer Res"},{"key":"BFtpj200919_CR11","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","volume":"22","author":"S Gurubhagavatula","year":"2004","unstructured":"Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC et al. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 2004; 22: 2594\u20132601.","journal-title":"J Clin Oncol"},{"issue":"4","key":"BFtpj200919_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/sj.tpj.6500463","volume":"8","author":"A Ruzzo","year":"2008","unstructured":"Ruzzo A, Graziano F, Loupakis F, Santini D, Catalano V, Bisonni R et al. Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy. Pharmacogenomics J 2008; 8 (4): 278\u2013288.","journal-title":"Pharmacogenomics J"},{"key":"BFtpj200919_CR13","doi-asserted-by":"crossref","unstructured":"Clark JC, Dass CR, Choong PF . A review of clinical molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol 2007.","DOI":"10.1007\/s00432-007-0330-x"},{"key":"BFtpj200919_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00432-007-0330-x","volume":"134","author":"JC Clark","year":"2008","unstructured":"Clark JC, Dass CR, Choong PF . A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol 2008; 134: 281\u2013297.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFtpj200919_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","volume":"91","author":"J Stoehlmacher","year":"2004","unstructured":"Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S et al. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer 2004; 91: 344\u2013354.","journal-title":"Br J Cancer"},{"key":"BFtpj200919_CR16","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1158\/1078-0432.CCR-06-2543","volume":"13","author":"DF Giachino","year":"2007","unstructured":"Giachino DF, Ghio P, Regazzoni S, Mandrile G, Novello S, Selvaggi G et al. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer. Clin Cancer Res 2007; 13: 2876\u20132881.","journal-title":"Clin Cancer Res"},{"key":"BFtpj200919_CR17","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdh319","volume":"15","author":"D Isla","year":"2004","unstructured":"Isla D, Sarries C, Rosell R, Alonso G, Domine M, Taron M et al. Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer. Ann Oncol 2004; 15: 1194\u20131203.","journal-title":"Ann Oncol"},{"key":"BFtpj200919_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.lungcan.2003.11.019","volume":"44","author":"JS Ryu","year":"2004","unstructured":"Ryu JS, Hong YC, Han HS, Lee JE, Kim S, Park YM et al. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. Lung Cancer 2004; 44: 311\u2013316.","journal-title":"Lung Cancer"},{"key":"BFtpj200919_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/carcin\/21.4.551","volume":"21","author":"RM Lunn","year":"2000","unstructured":"Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 2000; 21: 551\u2013555.","journal-title":"Carcinogenesis"},{"key":"BFtpj200919_CR20","first-page":"1354","volume":"61","author":"MR Spitz","year":"2001","unstructured":"Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001; 61: 1354\u20131357.","journal-title":"Cancer Res"},{"key":"BFtpj200919_CR21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/carcin\/21.5.965","volume":"21","author":"EJ Duell","year":"2000","unstructured":"Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000; 21: 965\u2013971.","journal-title":"Carcinogenesis"},{"key":"BFtpj200919_CR22","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.dnarep.2005.07.001","volume":"4","author":"SG Clarkson","year":"2005","unstructured":"Clarkson SG, Wood RD . Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair (Amst) 2005; 4: 1068\u20131074.","journal-title":"DNA Repair (Amst)"},{"key":"BFtpj200919_CR23","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ijc.20911","volume":"115","author":"Z Hu","year":"2005","unstructured":"Hu Z, Wang Y, Wang X, Liang G, Miao X, Xu Y et al. DNA repair gene XPC genotypes\/haplotypes and risk of lung cancer in a Chinese population. Int J Cancer 2005; 115: 478\u2013483.","journal-title":"Int J Cancer"},{"key":"BFtpj200919_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2004.11.016","volume":"222","author":"U Vogel","year":"2005","unstructured":"Vogel U, Overvad K, Wallin H, Tj\u00f8nneland A, Nex\u00f8 BA, Raaschou-Nielsen O et al. Combinations of polymorphisms in XPD XPC and XPA in relation to risk of lung cancer. Cancer Lett 2005; 222: 67\u201374.","journal-title":"Cancer Lett"},{"key":"BFtpj200919_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1479-5876-5-70","volume":"5","author":"J Oldenburg","year":"2007","unstructured":"Oldenburg J, Kraggerud SM, Bryd\u00f8y M, Cvancarova M, Lothe RA, Fossa SD et al. Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in lutathione-s-transferase-P1 and -M1, a retrospective cross sectional study. J Transl Med 2007; 5: 70.","journal-title":"J Transl Med"},{"key":"BFtpj200919_CR26","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/carcin\/21.10.1821","volume":"21","author":"SG Khan","year":"2000","unstructured":"Khan SG, Metter EJ, Tarone RE, Bohr VA, Grossman L, Hedayati M et al. A new xeroderma pigmentosum group C poly (AT) insertion\/deletion polymorphism. Carcinogenesis 2000; 21: 1821\u20131825.","journal-title":"Carcinogenesis"},{"issue":"2","key":"BFtpj200919_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.dnarep.2007.08.006","volume":"7","author":"Y Zhu","year":"2008","unstructured":"Zhu Y, Yang H, Chen Q, Lin J, Grossman HB, Dinney CP et al. Modulation of DNA damage\/DNA repair capacity by XPC polymorphisms. DNA Repair (Amst) 2008; 7 (2): 141\u2013148.","journal-title":"DNA Repair (Amst)"},{"key":"BFtpj200919_CR28","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1158\/1078-0432.CCR-04-0247","volume":"10","author":"W Zhou","year":"2004","unstructured":"Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC et al. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 2004; 10: 4939\u20134943.","journal-title":"Clin Cancer Res"},{"key":"BFtpj200919_CR29","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-04-2216","volume":"11","author":"J Viguier","year":"2005","unstructured":"Viguier J, Boige V, Miquel C, Pocard M, Giraudeau B, Sabourin JC et al. ERCC1 2004, codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin\/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer. Clin Cancer Res 2005; 11: 6212\u20136217.","journal-title":"Clin Cancer Res"},{"key":"BFtpj200919_CR30","doi-asserted-by":"publisher","first-page":"9420","DOI":"10.1158\/0008-5472.CAN-06-1418","volume":"66","author":"RL Milne","year":"2006","unstructured":"Milne RL, Ribas G, Gonz\u00e1lez-Neira A, Fagerholm R, Salas A, Gonz\u00e1lez E et al. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping. Cancer Res 2006; 66: 9420\u20139427.","journal-title":"Cancer Res"},{"key":"BFtpj200919_CR31","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.ijrobp.2006.06.029","volume":"66","author":"J Carles","year":"2006","unstructured":"Carles J, Monzo M, Amat M, Jansa S, Artells R, Navarro A, Foro P et al. Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006; 66: 1022\u20131030.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFtpj200919_CR32","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1002\/cncr.11456","volume":"97","author":"G Bacci","year":"2003","unstructured":"Bacci G, Bertoni F, Longhi A, Ferrari S, Forni C, Biagini R et al. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 2003; 97: 3068\u20133075.","journal-title":"Cancer"},{"key":"BFtpj200919_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/0471722146","volume-title":"Applied Logistic Regression","author":"DWLS Hosmer","year":"2000","unstructured":"Hosmer DW LS . Applied Logistic Regression. John Wiley & Sons: New York, 2000."},{"key":"BFtpj200919_CR34","volume-title":"Applied Survival Analysis: Regression Modeling of Time to Event Data","author":"DWLS Hosmer","year":"1999","unstructured":"Hosmer DW LS . Applied Survival Analysis: Regression Modeling of Time to Event Data. John Wiley & Sons: New York, 1999."}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj200919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj200919","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj200919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:22:12Z","timestamp":1647944532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj200919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,12]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["BFtpj200919"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2009.19","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,12]]},"assertion":[{"value":"19 December 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}